Cagrilintide 10 mg Cagrilintide 10 mg
Dragon Pharma

Cagrilintide 10 mg

CAGRILINTIDE ACETATE 10 MG INJECTION
Drug Class: Amylin Analog
Composition:
- Active Substance: Cagrilintide Acetate
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report

100.00 USD
Shipping From:
International
U.S. Domestic

Cagrilintide 10 mg Detailed

0.Cagrilintide Acetate 10 mg by Dragon Pharma – Amylin Analog for Appetite Regulation

Ca

grilintide Acetate 10 mg by Dragon Pharma is a synthetic amylin analog developed to enhance satiety, suppress appetite, and support weight loss. It mimics the effects of the naturally occurring hormone amylin, which works in tandem with insulin to help regulate gastric emptying and food intake.

What is Cagrilintide?

Cagrilintide is a long-acting amylin receptor agonist designed for subcutaneous use. It helps reduce caloric intake by delaying gastric emptying and promoting a sense of fullness. According to published clinical trials, Cagrilintide has shown synergistic effects when combined with GLP-1 analogs, making it a promising agent in obesity management.

Why Choose Cagrilintide by Dragon Pharma?

This research-grade version of Cagrilintide by Dragon Pharma is formulated at 10 mg per 2 mL vial, offering consistent dosing and purity. Produced in Europe under GMP conditions and lab tested for authenticity, it is trusted by medical researchers and advanced users pursuing cutting-edge metabolic support.

Lab Test Report

cagrilintide lab test report

Key Benefits

  • Reduces appetite and food cravings
  • Delays gastric emptying for improved satiety
  • May complement GLP-1 agonists like Semaglutide
  • Non-stimulant compound – no jittery effects
  • Single-dose weekly injection protocol (pending guidance)

Suggested Usage

Cagrilintide is administered via subcutaneous injection. Research protocols typically involve once-weekly dosing, often starting between 0.3–0.6 mg and titrating up to 2.4 mg or more depending on study goals. The 10 mg vial allows multiple titrated doses. Note: For research purposes only. Not approved for medical or dietary use.

Related Dragon Pharma Products for Stacking

  • Semaglutide 5 mg – popular GLP-1 receptor agonist for synergistic fat loss
  • GHRP-6 – for increased GH pulse and metabolic support
  • BPC-157 – for gut healing and inflammation control
  • AOD-9604 – fat-burning peptide focused on lipolysis
  • GHK-Cu 10 mg – for skin, recovery, and metabolic health

Who Uses Cagrilintide?

Ideal for advanced users or researchers exploring novel weight loss strategies, especially when stacked with GLP-1 therapies. It's gaining popularity in cutting-edge metabolic research, particularly for those with obesity, insulin resistance, or appetite dysregulation.

FAQ: Cagrilintide 10 mg by Dragon Pharma

What is Cagrilintide used for?

Cagrilintide is a synthetic amylin analog used in research for appetite suppression, delayed gastric emptying, and weight loss. It mimics the natural hormone amylin, which works with insulin to regulate food intake.

How is Cagrilintide administered?

Cagrilintide is administered via subcutaneous injection. In research, it is commonly dosed once weekly. Dosage depends on study goals, often starting low and titrating upward.

Can Cagrilintide be combined with other peptides?

Yes. Cagrilintide is often studied in combination with GLP-1 receptor agonists like Semaglutide, showing synergistic effects on weight loss and appetite control.

What are the benefits of using Cagrilintide?

Reported benefits include reduced appetite, prolonged satiety, lower caloric intake, and steady fat loss. It is non-stimulant and typically well-tolerated in research settings.

Is Dragon Pharma Cagrilintide tested for purity?

Yes. Dragon Pharma Cagrilintide 10 mg is lab-tested for purity and concentration. It is manufactured under strict GMP standards and includes a lab report for transparency.

No reviews found

Please log in to write Cagrilintide 10 mg review.

Related Offers
US Domestic & International
Sermorelin 5 mg
Dragon Pharma, Europe

SERMORELIN 5 MG INJECTION
Drug Class: Growth Hormone-Releasing Hormone (GHRH)
Composition:
- Active Substance: Sermorelin
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma

45.00 USD  
US Domestic & International
PT-141 10 mg
Dragon Pharma, Europe

BREMELANOTIDE 10 MG INJECTION
Drug Class: Selective Melanocortin Receptor Agonist
Composition:
- Active Substance: Bremelanotide
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma

45.00 USD  
Lab Tested
US Domestic & International
BPC 157 5 mg
Dragon Pharma, Europe

PENTADECAPEPTIDE 2 MG INJECTION
Drug Class: Healing/Repair Peptide
Composition:
- Active Substance: Pentadecapeptide
- Concentration: 5 mg/vial
Presentation: 5 mL Vial
Form: Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report

40.00 USD  
US Domestic & International
Tesamorelin 5 mg
Dragon Pharma, Europe

TESAMORELIN 5 MG INJECTION
Drug Class: Growth Hormone-Releasing Hormone (GHRH)
Composition:
- Active Substance: Tesamorelin
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma

70.00 USD  
Lab Tested
US Domestic & International
Tirze-Pep 5 mg
Dragon Pharma, Europe

TIRZE-PEP 5 MG INJECTION
Drug Class: Dual GLP-1/GIP Peptide
Composition:
- Active Substance: Tirzepatide
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report

90.00 USD  

Add in Cart - Product(s)

Close Button
Empty

Total Cost: